Search Result
Results for "
impurity synthesis
" in MedChemExpress (MCE) Product Catalog:
2
Biochemical Assay Reagents
7
Isotope-Labeled Compounds
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-W010712
-
|
|
Amino Acid Derivatives
|
Others
|
|
Fmoc-His(Trt)-OH is a histidine derivative with a trityl (Trt) group protecting the His side chain. Fmoc-His(Trt)-OH also has an Fmoc group protecting the α-NH2 group. Fmoc-His(Trt)-OH can be used in solid-phase peptide synthesis to prevent racemization and byproduct formation. Fmoc-His(Trt)-OH acts as a protected histidine precursor in solid-phase peptide synthesis (SPPS), participating in peptide chain construction through amide bond formation. Fmoc-His(Trt)-OH can be precisely incorporated into the target peptide sequence, ensuring correct peptide chain synthesis and reducing impurity formation. Fmoc-His(Trt)-OH is mainly used in the solid-phase synthesis research of pharmaceutical peptides and bioactive peptides, and is particularly suitable for the preparation of peptide drugs requiring precise control of histidine configuration .
|
-
-
- HY-13036A
-
|
|
Btk
|
Cancer
|
|
IBT6A is an impurity of Ibrutinib. IBT6A can be used in synthesis of IBT6A Ibrutinib dimer and IBT6A adduct . Ibrutinib is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM .
|
-
-
- HY-W035903
-
|
2-Aminoethanol hydrochloride
|
Biochemical Assay Reagents
|
Others
|
|
Ethanolamine hydrochloride, is an organic compound used in various industrial applications. It is a white or colorless solid that is soluble in water and has a faint odor. One of the major uses of Ethanolamine hydrochloride is in the production of detergents and surfactants. Used as a raw material in the manufacture of compounds such as ethylenediaminetetraacetic acid (EDTA) and diethanolamine, which are commonly used in household and industrial cleaning products. Ethanolamine hydrochloride is also used in the synthesis of pharmaceuticals, agrochemicals and rubber processing agents. It acts as a buffer in certain chemical reactions, helping to adjust pH and maintain stability. Ethanolamine hydrochloride can be used for gas purification and metal corrosion inhibitor. Its ability to react with acid gases such as carbon dioxide and sulfur dioxide makes it useful for removing impurities from natural gas and other industrial gases. Overall, Ethanolamine hydrochloride is a multifunctional compound with many potential industrial applications. Its ability to act as a buffer, chelating agent, and corrosion inhibitor makes it an important tool in a variety of industries.
|
-
-
- HY-78727
-
|
IBT4A
|
Drug Intermediate
Btk
|
Inflammation/Immunology
Cancer
|
|
Ibrutinib deacryloylpiperidine (IBT4A) is a derivative of an Ibrutinib (HY-10997) intermediate and an Ibrutinib impurity. Ibrutinib deacryloylpiperidine serves as a starting material and is used in the synthesis of a modified BTK inhibitor derivative via the Mitsunobu reaction .
|
-
-
- HY-43384
-
|
Tenofovir impurity 66
|
Drug Intermediate
|
Others
|
|
Chloromethyl methyl carbonate (Tenofovir Impurity 66) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-W206016
-
|
3-ASA
|
Drug Intermediate
|
Others
|
|
3-Aminosalicylic acid (3-ASA) is a hydroxybenzoic acid compound. 3-Aminosalicylic acid serves as a building block for organic synthesis. It also acts as a potential impurity of 5-Aminosalicylic Acid (HY-15027) .
|
-
-
- HY-66004
-
|
Diacetamate
|
Drug Intermediate
Bacterial
Parasite
|
Inflammation/Immunology
Cancer
|
|
4-Acetamidophenyl acetate is an impurity of Acetaminophen (HY-66005). 4-Acetamidophenyl acetate acts as an intermediate in the synthesis of Acetaminophen. Acetaminophen is a selective COX-2 inhibitor (IC50=25.8 μM), and is a potent hepatic N-acetyltransferase 2 (NAT2) inhibitor .
|
-
-
- HY-131280
-
-
-
- HY-59121A
-
|
|
Drug Intermediate
|
Infection
|
|
Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate can be used to synthesis Sofosbuvir (HY-15005) to avoid the production of sofibuvir degradation impurities .
|
-
-
- HY-Z9064
-
|
|
Drug Intermediate
|
Others
|
|
1-epi-Regadenoson ethyl ester is an intermediate in the synthesis of αisomer impurity of Regadenoson which is a highly selective adenosine A2A receptor agonist .
|
-
-
- HY-79716
-
|
Pazopanib impurity
|
Drug Intermediate
|
Others
|
|
2,3-Dimethyl-6-nitro-2H-indazole (Pazopanib Impurity) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-W016644
-
-
-
- HY-W036121
-
-
-
- HY-133624
-
|
|
Drug Metabolite
|
Cancer
|
|
1,1,3-Tribromoacetone is an impurity of Methotrexate (HY-14519) . Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis .
|
-
-
- HY-B2121
-
|
6-MNA; Naproxen impurity O
|
Drug Metabolite
COX
|
Neurological Disease
Inflammation/Immunology
|
|
6-Methoxy-2-naphthoic acid (6-MNA) is the active metabolite of Nabumetone (HY-B0559). 6-Methoxy-2-naphthoic acid is also an inhibitor of COX-1 and COX-2. 6-Methoxy-2-naphthoic acid can inhibit the synthesis of gastric mucosal prostaglandin E2. 6-Methoxy-2-naphthoic acid can be used in the research of inflammation and pain-related diseases. In addition, 6-Methoxy-2-naphthoic acid is an impurity in Naproxen (HY-15030) and can also be used in the synthesis of other active compounds .
|
-
-
- HY-W072385
-
-
-
- HY-W018697
-
|
Dapagliflozin impurity 50
|
Drug Intermediate
|
Others
|
|
3-Bromo-4-chlorobenzoic acid (Dapagliflozin Impurity 50) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-W016194
-
|
1-Carboxycyclohexaneacetic acid; Gabapentin impurity E; Gabapentin Related Compound E
|
5-HT Receptor
|
Neurological Disease
|
|
1-(Carboxymethyl)cyclohexanecarboxylic acid (1-Carboxycyclohexaneacetic acid; Gabapentin Impurity E) is a potential impurity in commercial preparations of the antiepileptic agent Gabapentin (HY-A0057). It is also used as a precursor for the synthesis of a serotonin (5-HT) receptor subtype 5-HT2A antagonist.
|
-
-
- HY-75318
-
|
Dronedarone impurity A
|
Drug Intermediate
|
Others
|
|
(5-Amino-2-butylbenzofuran-3-yl)(4-(3-(dibutylamino)propoxy)phenyl)methanone (Dronedarone impurity A) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-78066
-
|
6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
|
Drug Intermediate
|
Others
|
|
Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-W043676
-
|
|
Parasite
Drug Intermediate
|
Infection
|
|
Dibenzosuberol (Compound 2) is a key intermediate in the synthesis of compounds associated with inhibiting Trypanosoma thiol reductase (TryR). Dibenzosuberol also shows inhibition of T. brucei with an EC50 value of 51.3 μM. Dibenzosuberol is also an impurity of Amitriptyline (HY-B0527) .
|
-
-
- HY-13036
-
|
|
Btk
|
Cancer
|
|
(Rac)-IBT6A is a racemate of IBT6A. IBT6A is an impurity of Ibrutinib. IBT6A can be used in synthesis of IBT6A Ibrutinib dimer and IBT6A adduct . Ibrutinib is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM .
|
-
-
- HY-42476
-
|
1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
|
Drug Intermediate
|
Others
|
|
Tolvaptan Impurity (1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-W036175
-
|
Metoclopramide impurity 12
|
Drug Intermediate
|
Others
|
|
4-Acetamido-5-chloro-2-methoxybenzoic acid (Metoclopramide Impurity 12) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-59121C
-
|
Sofosbuvir impurity 4/Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-D-alaninate
|
Drug Intermediate
|
Others
|
|
Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-D-alaninate (Sofosbuvir impurity 4/Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-D-alaninate) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-Y1066
-
|
Diethylene glycol monochlorohydrin
|
Drug Intermediate
|
Others
|
|
2-(2-Chloroethoxy)ethanol (Diethylene glycol monochlorohydrin) is an unclassified residual solvent and known impurity, with an acceptance criterion of 0.10%.2-(2-Chloroethoxy)ethanol serves as a starting material in quetiapine synthesis .
|
-
-
- HY-135397
-
|
(R)-PNU-100766
|
Drug Metabolite
|
Infection
|
|
(R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis .
|
-
-
- HY-13036B
-
|
|
Btk
|
Cancer
|
|
IBT6A hydrochloride is an impurity of Ibrutinib. IBT6A can be used in synthesis of IBT6A Ibrutinib dimer and IBT6A adduct . Ibrutinib is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM .
|
-
-
- HY-179396
-
|
|
Bacterial
|
Infection
|
|
T-1228 is a highly selective LpxC inhibitor. T-1228 can effectively block the synthesis of LPS (HY-D1056), causing defects in the bacterial outer membrane structure, increasing membrane permeability, and ultimately leading to bacterial cell death. T-1228 can be used for the study of Gram-negative bacterial infections .
|
-
-
- HY-66004R
-
|
Diacetamate (Standard)
|
Reference Standards
Drug Intermediate
Bacterial
Parasite
|
Inflammation/Immunology
Cancer
|
|
4-Acetamidophenyl acetate (Standard) is the analytical standard of 4-Acetamidophenyl acetate (HY-66004). This product is intended for research and analytical applications. 4-Acetamidophenyl acetate is an impurity of Acetaminophen (HY-66005). 4-Acetamidophenyl acetate acts as an intermediate in the synthesis of Acetaminophen. Acetaminophen is a selective COX-2 inhibitor (IC50=25.8 μM), and is a potent hepatic N-acetyltransferase 2 (NAT2) inhibitor .
|
-
-
- HY-W585843
-
|
|
Interleukin Related
|
Inflammation/Immunology
|
|
1,1′-Ethylidenebis[L-tryptophan] is an impurity in the synthesis of L-tryptophan. 1,1′-Ethylidenebis[L-tryptophan] promotes the proliferation of eosinophilic leukemia cells, induces the release of eosinophil cationic protein from eosinophils, and stimulates T cells to produce IL-5. 1,1′-Ethylidenebis[L-tryptophan] (40 µg/kg) can induce fascia thickening, mast cell infiltration, and fibrosis in adipose and subcutaneous muscle tissues in mice. 1,1′-Ethylidenebis[L-tryptophan] can be used in immunology and inflammation research .
|
-
-
- HY-Z8863
-
-
-
- HY-76937
-
|
|
VD/VDR
|
Endocrinology
|
|
Impurity of Doxercalciferol is an impurity of doxercalciferol, which is a synthetic analog of ergocalciferol (vitamin D2), used as a agent for secondary hyperparathyroidism and metabolic bone disease, and it suppresses parathyroid synthesis and secretion.
|
-
-
- HY-119326
-
-
-
- HY-131391
-
|
|
Drug Intermediate
|
Others
|
|
m-Isobutyl Ibuprofen (Compound IMP-A) is the impurity found during synthesis of Ibuprofen (HY-78131) .
|
-
-
- HY-Z9065
-
|
|
Drug Intermediate
|
Others
|
|
1-epi-Regadenoson hydrazone is an intermediate in the synthesis of αisomer impurity of Regadenoson which is a highly selective adenosine A2A receptor agonist .
|
-
-
- HY-17626B
-
|
WCK-2349 hydrochloride
|
Antibiotic
|
Infection
|
|
Alalevonadifloxacin (hydrochloride) (WCK-2349 (hydrochloride)) is a oraaly active anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotic .
|
-
-
- HY-134554
-
|
|
Drug Derivative
|
Cancer
|
|
5′-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine is an impurity in the synthesis of Capecitabine (HY-B0016) .
|
-
-
- HY-120955
-
|
|
Prostaglandin Receptor
|
Others
|
|
Cloprostol, a synthetic derivative of prostaglandin F2α, is used as an ossified in veterinary medicine and the research of reproductive disorders in cattle, pigs and horses. (+)-5-trans Cloprostenol is a secondary impurity produced during the synthesis of (+) -cloprostenol .
|
-
-
- HY-163967
-
|
|
Biochemical Assay Reagents
Bacterial
|
Infection
|
|
Clindamycin 2,4-diphosphate is a related impurity of Clindamycin phosphate (HY-B1064), a prodrug of Clindamycin (HY-B1455). Clindamycin phosphate inhibits protein synthesis by targeting the bacterial ribosomal 50S subunit .
|
-
-
- HY-135774R
-
|
|
Reference Standards
Drug Metabolite
Phosphatase
|
Cardiovascular Disease
|
|
1-(Carboxymethyl)cyclohexanecarboxylic acid (Standard) is the analytical standard of 1-(Carboxymethyl)cyclohexanecarboxylic acid. This product is intended for research and analytical applications. 1-(Carboxymethyl)cyclohexanecarboxylic acid (1-Carboxycyclohexaneacetic acid; Gabapentin Impurity E) is a potential impurity in commercial preparations of the antiepileptic agent Gabapentin (HY-A0057). It is also used as a precursor for the synthesis of a serotonin (5-HT) receptor subtype 5-HT2A antagonist.
|
-
-
- HY-W016194R
-
|
1-Carboxycyclohexaneacetic acid (Standard); Gabapentin impurity E (Standard); Gabapentin Related Compound E (Standard)
|
5-HT Receptor
Reference Standards
|
Neurological Disease
|
|
1-(Carboxymethyl)cyclohexanecarboxylic acid (Standard) is the analytical standard of 1-(Carboxymethyl)cyclohexanecarboxylic acid. This product is intended for research and analytical applications. 1-(Carboxymethyl)cyclohexanecarboxylic acid (1-Carboxycyclohexaneacetic acid; Gabapentin Impurity E) is a potential impurity in commercial preparations of the antiepileptic agent Gabapentin (HY-A0057). It is also used as a precursor for the synthesis of a serotonin (5-HT) receptor subtype 5-HT2A antagonist.
|
-
-
- HY-W767047
-
|
|
Isotope-Labeled Compounds
Drug Intermediate
|
Others
|
|
α-Hydroxymethyl atropine-d5 is the deuterium labeled α-Hydroxymethyl atropine (HY-W587927). α-Hydroxymethyl atropine is the impurity, that could be produced in process of Atropine (HY-B1205) synthesis .
|
-
-
- HY-13036C
-
|
|
Btk
|
Cancer
|
|
(Rac)-IBT6A hydrochloride is a racemate of IBT6A hydrochloride. IBT6A is an impurity of Ibrutinib. IBT6A can be used in synthesis of IBT6A Ibrutinib dimer and IBT6A adduct . Ibrutinib is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM .
|
-
-
- HY-135397R
-
|
(R)-PNU-100766 (Standard)
|
Drug Metabolite
Reference Standards
|
Infection
|
|
(R)-Linezolid (Standard) is the analytical standard of (R)-Linezolid. This product is intended for research and analytical applications. (R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis .
|
-
-
- HY-W394935
-
|
Disulfide,bis(2,4-dimethylphenyl)
|
Biochemical Assay Reagents
|
Others
|
|
Dixylyl disulphide (Disulfide, bis(2,4-dimethylphenyl)) is a 1,2-bis(2,4-dimethylphenyl) thioether that can serve as an impurity reference standard for hydrobromide vortioxetine, used for monitoring impurities in the synthesis process. Hydrobromide vortioxetine is a 5-HT3, 5-HT7, and 5-HT1D receptor antagonist and a 5-HT1A receptor agonist, exhibiting antidepressant activity .
|
-
-
- HY-W206016S
-
|
3-ASA-d3
|
Isotope-Labeled Compounds
|
Others
|
|
3-Aminosalicylic acid-d3 is deuterium labeled 3-Aminosalicylic acid. 3-Aminosalicylic acid (3-ASA) is a hydroxybenzoic acid compound. 3-Aminosalicylic acid serves as a building block for organic synthesis. It also acts as a potential impurity of 5-Aminosalicylic Acid (HY-15027) .
|
-
-
- HY-135397S
-
|
|
Isotope-Labeled Compounds
|
Infection
|
|
(R)-Linezolid-d3 ((R)-PNU-100766-d3) is the deuterium labeled (R)-Linezolid. (R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis .
|
-
-
- HY-104077S2
-
|
|
Isotope-Labeled Compounds
DNA/RNA Synthesis
SARS-CoV
|
Infection
|
|
Remdesivir impurity 9-d4 is deuterium labeled Remdesivir (HY-104077). Remdesivir (GS-5734) is a nucleoside analogue with effective antiviral activity. Remdesivir can inhibit the synthesis of viral DNA or RNA. Remdesivir can be used for the research of infection, such as SARS-CoV and MHV infection .
|
-
-
- HY-78558
-
|
3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
|
Drug Intermediate
|
Others
|
|
Tofacitinib Impurity T (3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide) is a drug intermediate for synthesis of various active compounds.
|
-
- HY-B2121R
-
|
6-MNA (Standard); Naproxen impurity O (Standard)
|
Reference Standards
Drug Metabolite
COX
|
Neurological Disease
Inflammation/Immunology
|
|
6-Methoxy-2-naphthoic acid (Standard) (6-MNA (Standard)) is the analytical standard of 6-Methoxy-2-naphthoic acid (HY-B2121). This product is intended for research and analytical applications. 6-Methoxy-2-naphthoic acid (6-MNA) is the active metabolite of Nabumetone (HY-B0559). 6-Methoxy-2-naphthoic acid is also an inhibitor of COX-1 and COX-2. 6-Methoxy-2-naphthoic acid can inhibit the synthesis of gastric mucosal prostaglandin E2. 6-Methoxy-2-naphthoic acid can be used in the research of inflammation and pain-related diseases. In addition, 6-Methoxy-2-naphthoic acid is an impurity in Naproxen (HY-15030) and can also be used in the synthesis of other active compounds.
|
-
- HY-130784
-
|
|
Drug Intermediate
|
Others
|
|
Dihydro montelukast (Impurity-3) is an impurity found during the synthesis of Montelukast sodium (HY-13315) .
|
-
- HY-131965
-
|
|
Drug Intermediate
|
Others
|
|
Imidacloprid impurity 1 (IMP-2) is the impurity found during the synthesis of Ivermectin (HY-15310) .
|
-
- HY-17675
-
|
|
Drug Intermediate
|
Cancer
|
|
Lorlatinib impurity-1 (Compound 4) is a drug intermediate that can be used for the synthesis of Lorlatinib (HY-12215) .
|
-
- HY-W720460
-
|
|
Drug Intermediate
|
Others
|
|
Lacosamide impurity 1 (Compound 2 in Figure 2 on page 6) is a Lacosamide impurity, and a key intermediate in the synthesis of Lacosamide .
|
-
- HY-178375S
-
|
|
Isotope-Labeled Compounds
Drug Intermediate
|
Others
|
|
Imidacloprid impurity 1-d4 is the deuterium labeled Imidacloprid impurity 1 (HY-131965). Imidacloprid impurity 1 (IMP-2) is the impurity found during the synthesis of Ivermectin (HY-15310) .
|
-
- HY-118515
-
-
- HY-W721593
-
|
|
Drug Intermediate
|
Others
|
|
(Rac)-Desmethyl lacosamide (formula V) is an Lacosamide impurity, and a key intermediate in the synthesis of Lacosamide .
|
-
- HY-W587927
-
|
|
Drug Intermediate
|
Others
|
|
α-Hydroxymethyl atropine is the impurity, that could be produced in process of Atropine (HY-B1205) synthesis .
|
-
- HY-49558
-
|
|
Biochemical Assay Reagents
|
Infection
|
|
7-Epiclindamycin is a common impurity in Clindamycin (HY-B1455) bulk agent. 7-epiclindamycin is produced during the synthesis of Clindamycin .
|
-
- HY-78066S1
-
|
6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d5
|
Isotope-Labeled Compounds
Drug Intermediate
|
Others
|
|
Abemaciclib impurity 1-d5 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d5) is the deuterium labeled Abemaciclib impurity 1. Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
|
-
- HY-78066S
-
|
6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d12
|
Isotope-Labeled Compounds
Drug Intermediate
|
Others
|
|
Abemaciclib impurity 1-d12 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d12) is the deuterium labeled Abemaciclib impurity 1. Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-W035903
-
|
2-Aminoethanol hydrochloride
|
Biochemical Assay Reagents
|
|
Ethanolamine hydrochloride, is an organic compound used in various industrial applications. It is a white or colorless solid that is soluble in water and has a faint odor. One of the major uses of Ethanolamine hydrochloride is in the production of detergents and surfactants. Used as a raw material in the manufacture of compounds such as ethylenediaminetetraacetic acid (EDTA) and diethanolamine, which are commonly used in household and industrial cleaning products. Ethanolamine hydrochloride is also used in the synthesis of pharmaceuticals, agrochemicals and rubber processing agents. It acts as a buffer in certain chemical reactions, helping to adjust pH and maintain stability. Ethanolamine hydrochloride can be used for gas purification and metal corrosion inhibitor. Its ability to react with acid gases such as carbon dioxide and sulfur dioxide makes it useful for removing impurities from natural gas and other industrial gases. Overall, Ethanolamine hydrochloride is a multifunctional compound with many potential industrial applications. Its ability to act as a buffer, chelating agent, and corrosion inhibitor makes it an important tool in a variety of industries.
|
-
- HY-163967
-
|
|
Biochemical Assay Reagents
|
|
Clindamycin 2,4-diphosphate is a related impurity of Clindamycin phosphate (HY-B1064), a prodrug of Clindamycin (HY-B1455). Clindamycin phosphate inhibits protein synthesis by targeting the bacterial ribosomal 50S subunit .
|
| Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-W010712
-
|
|
Amino Acid Derivatives
|
Others
|
|
Fmoc-His(Trt)-OH is a histidine derivative with a trityl (Trt) group protecting the His side chain. Fmoc-His(Trt)-OH also has an Fmoc group protecting the α-NH2 group. Fmoc-His(Trt)-OH can be used in solid-phase peptide synthesis to prevent racemization and byproduct formation. Fmoc-His(Trt)-OH acts as a protected histidine precursor in solid-phase peptide synthesis (SPPS), participating in peptide chain construction through amide bond formation. Fmoc-His(Trt)-OH can be precisely incorporated into the target peptide sequence, ensuring correct peptide chain synthesis and reducing impurity formation. Fmoc-His(Trt)-OH is mainly used in the solid-phase synthesis research of pharmaceutical peptides and bioactive peptides, and is particularly suitable for the preparation of peptide drugs requiring precise control of histidine configuration .
|
-
- HY-59121A
-
|
|
Drug Intermediate
|
Infection
|
|
Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate can be used to synthesis Sofosbuvir (HY-15005) to avoid the production of sofibuvir degradation impurities .
|
| Cat. No. |
Product Name |
Chemical Structure |
-
- HY-W767047
-
|
|
|
α-Hydroxymethyl atropine-d5 is the deuterium labeled α-Hydroxymethyl atropine (HY-W587927). α-Hydroxymethyl atropine is the impurity, that could be produced in process of Atropine (HY-B1205) synthesis .
|
-
-
- HY-W206016S
-
|
|
|
3-Aminosalicylic acid-d3 is deuterium labeled 3-Aminosalicylic acid. 3-Aminosalicylic acid (3-ASA) is a hydroxybenzoic acid compound. 3-Aminosalicylic acid serves as a building block for organic synthesis. It also acts as a potential impurity of 5-Aminosalicylic Acid (HY-15027) .
|
-
-
- HY-135397S
-
|
|
|
(R)-Linezolid-d3 ((R)-PNU-100766-d3) is the deuterium labeled (R)-Linezolid. (R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis .
|
-
-
- HY-104077S2
-
|
|
|
Remdesivir impurity 9-d4 is deuterium labeled Remdesivir (HY-104077). Remdesivir (GS-5734) is a nucleoside analogue with effective antiviral activity. Remdesivir can inhibit the synthesis of viral DNA or RNA. Remdesivir can be used for the research of infection, such as SARS-CoV and MHV infection .
|
-
-
- HY-178375S
-
|
|
|
Imidacloprid impurity 1-d4 is the deuterium labeled Imidacloprid impurity 1 (HY-131965). Imidacloprid impurity 1 (IMP-2) is the impurity found during the synthesis of Ivermectin (HY-15310) .
|
-
-
- HY-78066S1
-
|
|
|
Abemaciclib impurity 1-d5 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d5) is the deuterium labeled Abemaciclib impurity 1. Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-78066S
-
|
|
|
Abemaciclib impurity 1-d12 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-d12) is the deuterium labeled Abemaciclib impurity 1. Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) is a drug intermediate for synthesis of various active compounds.
|
-
| Cat. No. |
Product Name |
|
Classification |
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: